JANUS HENDERSON GROUP PLC
JHGNYSEFinancials · Investment Advice · Y9 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $3.10B | $2.47B | $2.10B | $2.20B | $2.77B | $2.30B |
| Operating income | $976.8M | $645.7M | $483.7M | $489.8M | $820.9M | $128.3M |
| Net income | $815.9M | $408.9M | $392.0M | $372.4M | $618.5M | $151.3M |
| Total assets | $8.29B | $6.96B | $6.50B | $6.24B | $6.70B | $6.69B |
| Total liabilities | $2.17B | $1.88B | $1.64B | $1.64B | $1.90B | $1.87B |
| Equity | $5.11B | $4.59B | $4.54B | $4.36B | $4.62B | $4.72B |
| EPS (diluted) | $5.23 | $2.56 | $2.37 | $2.23 | $3.57 | $0.70 |
| Shares out. | 157.6M | 161.7M | 165.7M | 169.0M | 172.3M | 187.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 31.5%
- Net margin
- 26.3%
- Return on equity
- 16.0%
- Return on assets
- 9.8%
- Return on capital (ROCE)
- 13.2%
- Liabilities / assets
- 26.1%
- Debt / equity
- 0.42×
- Book value / share
- $32.42
- Revenue growth (YoY)
- 25.2%
- Net income growth (YoY)
- 99.5%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 6.15safe
- Accruals / assets
- 1.2%clean
- Piotroski F-Score
- 8/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 7 good- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Trian Fund Management, L.P.Activist (13D)May 14, 2026
- Blackrock, Inc.Passive (13G)Apr 24, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Massachusetts Mutual Life Insurance CoActivist (13D)Dec 23, 2025
- Millennium Management LlcPassive (13G)May 16, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Frank Joshua D.Director | May 12, 2026 | Sell | 6.2M | $51.60 |
| Baldwin Brian MDirector | May 12, 2026 | Sell | 6.2M | $51.60 |
| Flood Eugene JrDirector | May 11, 2026 | Grant | 3,288 | $51.71 |
| Desai KalpanaDirector | May 11, 2026 | Grant | 3,288 | $51.71 |
| Dolan Kevin BDirector | May 11, 2026 | Grant | 3,288 | $51.71 |
| Sheehan AnneDirector | May 11, 2026 | Grant | 3,288 | $51.71 |
| Cassaday John MDirector | May 11, 2026 | Grant | 5,899 | $51.71 |
| Quirk Alison A.Director | May 11, 2026 | Grant | 3,288 | $51.71 |
| Seymour Jackson AngelaDirector | May 11, 2026 | Grant | 3,288 | $51.71 |
| Seidman LeslieDirector | May 11, 2026 | Grant | 3,288 | $51.71 |
| Podzorov MeganOfficer — Chief People Officer | Mar 10, 2026 | Sell | 1,650 | $51.24 |
| Rosenberg MichelleOfficer — CAO & GENERAL COUNSEL | Feb 27, 2026 | Grant | 29,388 | $49.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 2.6M | 1.0 | +5.6% |
| Apr 30, 2026 | 2.5M | 1.7 | -3.5% |
| Apr 15, 2026 | 2.6M | 1.2 | -18.4% |
| Mar 31, 2026 | 3.2M | 1.0 | +13.8% |
| Mar 13, 2026 | 2.8M | 1.1 | +45.2% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 8, 2026
- Shareholder voteApr 17, 2026
- Regulation FD disclosureMar 25, 2026
- Entered a material agreement · Other material eventMar 24, 2026
- Results of operationsJan 30, 2026
- Entered a material agreement · Other material eventDec 22, 2025
- Results of operationsOct 30, 2025
- Other material eventOct 27, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 13F-HR/AMay 18, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026